Found: 25
Select item for more details and to access through your institution.
Advanced mast cell disease: an Italian Hematological Multicenter experience.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia.
- Published in:
- Cancer Reports, 2024, v. 7, n. 8, p. 1, doi. 10.1002/cnr2.2141
- By:
- Publication type:
- Article
Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 845, doi. 10.1111/bjh.17405
- By:
- Publication type:
- Article
Rearrangements of ATP5L‐KMT2A in acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e139, doi. 10.1111/bjh.17265
- By:
- Publication type:
- Article
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00468-7
- By:
- Publication type:
- Article
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 303, doi. 10.3390/cancers12020303
- By:
- Publication type:
- Article
Issue Highlights—July 2022.
- Published in:
- Cytometry. Part B, 2022, v. 102, n. 4, p. 267, doi. 10.1002/cyto.b.22089
- By:
- Publication type:
- Article
Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.684396
- By:
- Publication type:
- Article
Letter to the Editor Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Novel insights and therapeutic approaches in secondary AML.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1400461
- By:
- Publication type:
- Article
MPN-180: A Novel Mechanism of Action of Midostaurin in Systemic Mastocytosis: Beyond KIT Inhibition.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S356, doi. 10.1016/S2152-2650(21)01823-1
- By:
- Publication type:
- Article
Poster: MPN-180: A Novel Mechanism of Action of Midostaurin in Systemic Mastocytosis: Beyond KIT Inhibition.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S233, doi. 10.1016/S2152-2650(21)01468-3
- By:
- Publication type:
- Article
Mast cell leukemia: a report of ten cases.
- Published in:
- 2008
- By:
- Publication type:
- Letter
PDGFRalpha/FIP1L1-positive chronic eosinophilic leukemia presenting with retro-orbital localization: efficacy of imatinib treatment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 713, doi. 10.1007/s00280-007-0507-7
- By:
- Publication type:
- Article
Successo terapeutico di CPX-351 nel trattamento di una leucemia acuta con aspetti correlati a mielodisplasia a rischio ELN intermedio. .
- Published in:
- Current Therapeutics, 2020, v. 23, n. 4, p. 9
- By:
- Publication type:
- Article
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3277
- By:
- Publication type:
- Article
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 692, doi. 10.1002/ajh.24382
- By:
- Publication type:
- Article
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 5, p. E80, doi. 10.1002/ajh.23966
- By:
- Publication type:
- Article
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a.
- Published in:
- Biomedicines, 2021, v. 9, n. 4, p. 388, doi. 10.3390/biomedicines9040388
- By:
- Publication type:
- Article
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.
- Published in:
- British Journal of Haematology, 2005, v. 131, n. 2, p. 172, doi. 10.1111/j.1365-2141.2005.05745.x
- By:
- Publication type:
- Article
A der(1)t(1;21)(p36.3;q22) in a Patient with Acute Myelogenous Leukemia M2.
- Published in:
- Acta Haematologica, 2010, v. 124, n. 1, p. 44, doi. 10.1159/000314075
- By:
- Publication type:
- Article
Correction to: Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
- Published in:
- Cell Biology & Toxicology, 2023, v. 39, n. 3, p. 795, doi. 10.1007/s10565-021-09640-x
- By:
- Publication type:
- Article